scispace - formally typeset
J

J. Scott VanEpps

Researcher at University of Michigan

Publications -  37
Citations -  1922

J. Scott VanEpps is an academic researcher from University of Michigan. The author has contributed to research in topics: Staphylococcus epidermidis & Biofilm. The author has an hindex of 12, co-authored 26 publications receiving 1262 citations. Previous affiliations of J. Scott VanEpps include University of Pittsburgh.

Papers
More filters
Journal ArticleDOI

Diverse Applications of Nanomedicine

Beatriz Pelaz, +91 more
- 14 Mar 2017 - 
TL;DR: An overview of recent developments in nanomedicine is provided and the current challenges and upcoming opportunities for the field are highlighted and translation to the clinic is highlighted.
Journal ArticleDOI

Unexpected insights into antibacterial activity of zinc oxide nanoparticles against methicillin resistant Staphylococcus aureus (MRSA)

TL;DR: The results of this study point to the importance of specific experimental controls in the interpretation of antimicrobial mechanistic studies and the need for targeted molecular mechanism studies on the antibacterial mechanisms of biomimetic ZnO-NPs.
Journal ArticleDOI

Shape-Dependent Biomimetic Inhibition of Enzyme by Nanoparticles and Their Antibacterial Activity.

TL;DR: It is shown that small zinc oxide nanoparticles-pyramids, plates, and spheres-possess the ability to inhibit activity of a typical enzyme β-galactosidase (GAL) in a biomimetic fashion and compares favorably to that of the best natural GAL inhibitors while being resistant to proteases.
Journal ArticleDOI

Implantable Device-Related Infection.

TL;DR: A length-scale conceptualization of device-related infection pathogenesis is provided, focusing specifically on biofilm formation and the role of host immune and coagulation systems.
Journal ArticleDOI

Antibacterial Metal Oxide Nanoparticles: Challenges in Interpreting the Literature.

TL;DR: Methods to evaluate MO-NPs antibacterial efficiency with focus on issues related to NPs in these assays are discussed, including sources of experimental variability including NP preparation, initial bacterial concentration, bacterial strains tested, culture microenvironment, and reported dose.